Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes-Reference-Cited by-同舟云学术

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

Published:2010-01 Issue:2 Volume:102 Page:301-315
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Glaspy J,Crawford J,Vansteenkiste J,Henry D,Rao S,Bowers P,Berlin J A,Tomita D,Bridges K,Ludwig H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605498.pdf

Reference114 articles.

1. Aapro M, Coiffier B, Dunst J, Osterborg A, Burger HU (2006) Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis. Br J Cancer 95: 1467–1473

2. Aapro M, Leonard RC, Barnadas A, Marangolo M, Untch M, Malamos N, Mayordomo J, Reichert D, Pedrini JL, Ukarma L, Scherhag A, Burger HU (2008a) Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study. J Clin Oncol 26: 592–598

3. Aapro M, Scherhag A, Burger HU (2008b) Effect of treatment with epoetin-beta on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients. Br J Cancer 99: 14–22

4. Abels R (1993) Erythropoietin for anaemia in cancer patients. Eur J Cancer 29A (Suppl 2): S2–S8

5. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A (2001) Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 61: 3561–3565

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia;Vox Sanguinis;2024-08-21

2. The effect of erythropoiesis‑stimulating agents on lung cancer patients: a meta‑analysis;Clinical and Experimental Medicine;2024-07-05

3. Prognostic impact of erythropoietin‐stimulating agent use during front‐line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study;International Journal of Gynecology & Obstetrics;2024-04-29

4. Hematopoietic Growth Factors;Pharmaceutical Biotechnology;2024

5. Novel Combination of Erythropoietin and Romiplostim to Treat Chemotherapy-Induced Anemia and Thrombocytopenia via Pharmacodynamic Interaction on Hematopoietic Stem and Progenitor Cells;ACS Pharmacology & Translational Science;2023-11-15